Constructs for Enhanced Production of Endothelial Nitric Oxide Synthase and Methods of Producing Cellular Compositions for Treatment of Pulmonary and Cardiac Diseases

MICROPARTICLE, PREVENTIVE DRUG OR THERAPEUTIC DRUG FOR ERECTILE DYSFUNCTION, AND METHOD FOR IMPROVING ERECTILE DYSFUNCTION

COMPOSITION AND METHODS TO REDUCE INFLAMMATION AND PROMOTE REJUVENATION

MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS

COMPOSITIONS AND METHODS FOR TREATMENT OF SEPSIS-RELATED DISORDERS

Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of NOS2, NOS3, VIP, KCNMA1, and CGRP genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-NOS2, or Escherichia coli strain SCS110-AF/VTvaf17-NOS3, or Escherichia coli strain SCS110-AF/VTvaf17-VIP, or Escherichia coli strain SCS110-AF/VTvaf17-KCNMA1, or Escherichia coli strain SCS110-AF/V

MIRNA INHIBITORS FOR PREVENTING AND TREATING ANEURYSMS, HYPERTENSION, ARDS AND OTHER DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION

Methods for producing modified bacteria for production of nitroaromatics

Modified bacteria for production of nitroaromatics

Compositions and methods for treatment of sepsis-related disorders

CYCLIC PEPTIDE INHIBITORS OF PSD-95 AND USES THEREOF

ENTERIC NITRERGIC NEURONS AND METHODS OF USING THE SAME

In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject

METHODS OF TREATING AN AUTOIMMUNE DISEASE

Modified bacteria for production of nitroaromatics

RNA preparations comprising purified modified RNA for reprogramming cells

Compositions and methods for treatment of sepsis-related disorders

REGULATING PROTEIN SPONTANEOUS RUPTURES

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

Modulation of fluid intake

In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject

Amphipathic peptide

Inhibiting UVB-Irradiation Damage By Targeting Nitric Oxide Synthases (cNOS)

Increased triacylglycerol production in microalgae

BIOFILMS, COMPONENTS AND METHODS OF USE TO REDUCE BIOFOULING AND CONTAMINATION

RNA preparations comprising purified modified RNA for reprogramming cells

Amphipathic peptide

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

Biofilms, components and methods of use to reduce biofouling and contamination

NITRIC OXIDE-MODULATING BONE-TARGETING COMPLEXES

RNA preparations comprising purified modified RNA for reprogramming cells

2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition

Cell penetrating protein adaptor molecules and their application in research and medicine

Nitric oxide synthase nanoparticles for treatment of vascular disease

Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria

Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery

Amphipathic peptide

Treatment of penetrative injury to the brain

Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition

METHODS FOR TREATING DISEASES

Compositions and methods for reprogramming eukaryotic cells

Treating oncogenic Ras driven cancers

MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE

Methods of Diagnosing, Preventing, and Treating Early Onset of Pulmonary Hypertension

Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase

Receptor antagonists as therapeutic agents for iNOS generating illness

Injection of bone marrow-derived conditioned medium for angiogenesis

Bioprosthetic heart valves

Antisense modulation of inducible nitric oxide synthase expression

Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases

Method of treatment of endothelial dysfunction and engineered proteins for same

Bacterial nitric oxide synthases and uses thereof